Eugenol and its association with levodopa in 6‐hydroxydopamine‐induced hemiparkinsonian rats: Behavioural and neurochemical alterations

Basic & Clinical Pharmacology & Toxicology Policy for Experimental and Clinical studies

(2018) Pernille Tveden-Nyborg et al.   BASIC & CLINICAL PHARMACOLOGY & TOXICOLOGY

Neuroprotective Effects of Sulphated Agaran from Marine AlgaGracilaria corneain Rat 6-Hydroxydopamine Parkinson's Disease Model: Behavioural, Neurochemical and Transcriptional Alterations

(2016) Ricardo Basto Souza et al.   BASIC & CLINICAL PHARMACOLOGY & TOXICOLOGY

Decreased synaptic plasticity in the medial prefrontal cortex underlies short-term memory deficits in 6-OHDA-lesioned rats

(2016) Filipe C. Matheus et al.   BEHAVIOURAL BRAIN RESEARCH

3-O-Methyldopa inhibits astrocyte-mediated dopaminergic neuroprotective effects of l-DOPA

(2016) Masato Asanuma et al.   BMC NEUROSCIENCE

Neurorestorative effects of eugenol, a spice bioactive: Evidence in cell model and its efficacy as an intervention molecule to abrogate brain oxidative dysfunctions in the streptozotocin diabetic rat

(2016) Sathya N. Prasad et al.   NEUROCHEMISTRY INTERNATIONAL

Striatal mRNA expression patterns underlying peak dose l-DOPA-induced dyskinesia in the 6-OHDA hemiparkinsonian rat

(2016) L.M. Smith et al.   NEUROSCIENCE

Animal behavioral assessments in current research of Parkinson’s disease

(2016) Tetsuya Asakawa et al.   NEUROSCIENCE AND BIOBEHAVIORAL REVIEWS

Oxidative stress and Parkinson's disease: New hopes in treatment with herbal antioxidants

(2015) Amir Sarrafchi et al.   CURRENT PHARMACEUTICAL DESIGN

Anti-oxidant polydatin (piceid) protects against substantia nigral motor degeneration in multiple rodent models of Parkinson’s disease

(2015) Yupin Chen et al.   Molecular Neurodegeneration

Neurobiology of rodent self-grooming and its value for translational neuroscience

(2015) Allan V. Kalueff et al.   NATURE REVIEWS NEUROSCIENCE

Long-term treatment with l-DOPA or pramipexole affects adult neurogenesis and corresponding non-motor behavior in a mouse model of Parkinson's disease

(2015) W.-H. Chiu et al.   NEUROPHARMACOLOGY

Anxiety in Parkinson's disease: Symptom dimensions and overlap with depression and autonomic failure

(2015) Sonja Rutten et al.   PARKINSONISM & RELATED DISORDERS

Dietary Factors in the Etiology of Parkinson’s Disease

(2015) Zeynep S. Agim et al.   Biomed Research International

Levodopa: Effect on cell death and the natural history of Parkinson's disease

(2014) C. Warren Olanow   MOVEMENT DISORDERS

Mechanisms of Body Weight Fluctuations in Parkinson’s Disease

(2014) Andrea Kistner et al.   Frontiers in Neurology

Locus Coeruleus Is Involved in Weight Loss in a Rat Model of Parkinson's Disease: An Effect Reversed by Deep Brain Stimulation

(2013) Joana Guimarães et al.   Brain Stimulation

Behavioral and Neurochemical Effects of Alpha-Lipoic Acid in the Model of Parkinson’s Disease Induced by Unilateral Stereotaxic Injection of 6-Ohda in Rat

(2013) Dayane Pessoa de Araújo et al.   Evidence-based Complementary and Alternative Medicine

Terpene Compounds in Nature: A Review of Their Potential Antioxidant Activity

(2012) E. Gonzalez-Burgos et al.   CURRENT MEDICINAL CHEMISTRY

Mitochondrial defects and oxidative stress in Alzheimer disease and Parkinson disease

(2012) Michael H. Yan et al.   FREE RADICAL BIOLOGY AND MEDICINE

Classic and New Animal Models of Parkinson's Disease

(2012) Javier Blesa et al.   JOURNAL OF BIOMEDICINE AND BIOTECHNOLOGY

Psychosis, apathy, depression and anxiety in Parkinson's disease

(2012) David A. Gallagher et al.   NEUROBIOLOGY OF DISEASE

Neuroprotective Efficacy of Eugenol and Isoeugenol in Acrylamide-Induced Neuropathy in rats: Behavioral and Biochemical evidence

(2012) Sathya N. Prasad et al.   NEUROCHEMICAL RESEARCH

Anti-Parkinsonian drug discovery from herbal medicines: What have we got from neurotoxic models?

(2011) Ju-Xian Song et al.   JOURNAL OF ETHNOPHARMACOLOGY

Antioxidant Activity of Eugenol: A Structure–Activity Relationship Study

(2011) İlhami Gülçin   JOURNAL OF MEDICINAL FOOD

Effects of Zingerone [4-(4-Hydroxy-3-Methoxyphenyl)-2-Butanone] and Eugenol [2-Methoxy-4-(2-Propenyl)Phenol] on the Pathological Progress in the 6-Hydroxydopamine-Induced Parkinson’s Disease Mouse Model

(2011) Hideaki Kabuto et al.   NEUROCHEMICAL RESEARCH

Neurotoxin-based models of Parkinson's disease

(2011) J. Bové et al.   NEUROSCIENCE

l-DOPA: A scapegoat for accelerated neurodegeneration in Parkinson's disease?

(2011) Janusz Lipski et al.   PROGRESS IN NEUROBIOLOGY

Eugenol (an essential oil of clove) acts as an antibacterial agent against Salmonella typhi by disrupting the cellular membrane

(2010) K. Pandima Devi et al.   JOURNAL OF ETHNOPHARMACOLOGY

Chemical physiology of oxidative stress-activated TRPM2 and TRPC5 channels

(2010) Shinichiro Yamamoto et al.   PROGRESS IN BIOPHYSICS & MOLECULAR BIOLOGY

Antifungal activity of the clove essential oil from Syzygium aromaticum on Candida, Aspergillus and dermatophyte species

(2009) E. Pinto et al.   JOURNAL OF MEDICAL MICROBIOLOGY

Parkinson's disease

(2009) Andrew J Lees et al.   LANCET

In vitroandin vivoeffects of clove on pro-inflammatory cytokines production by macrophages

(2009) T.G. Rodrigues et al.   NATURAL PRODUCT RESEARCH

Investigation of antioxidant, anti-inflammatory and DNA-protective properties of eugenol in thioacetamide-induced liver injury in rats

(2009) Baskaran Yogalakshmi et al.   TOXICOLOGY